{
  "trial_id": "NCT00079274",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race/ethnicity, performance status (ECOG), absolute neutrophil count, platelet count, hemoglobin level, bilirubin level, creatinine level, KRAS status, presence of synchronous primary colon cancer, number of pathologically confirmed positive lymph nodes, history of tumor-related obstructions, history of colonic perforation, history of other malignancies within the past 5 years, history of cardiovascular conditions (e.g., high blood pressure, angina, congestive heart failure, myocardial infarction, heart disease), history of pulmonary conditions (e.g., pulmonary fibrosis, interstitial pneumonitis), history of allergic reactions to monoclonal antibody therapy or platinum compounds, presence of human anti-mouse antibodies (HAMA), HIV status, pregnancy status, history of gastrointestinal bleeding, presence of peripheral sensory or motor neuropathy, history of other concurrent medical conditions, prior chemotherapy or radiotherapy for colon cancer, concurrent use of biologic therapy, chemotherapy, or targeted agents.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race/ethnicity"
        ],
        [
          "Positive Nodes",
          "number of pathologically confirmed positive lymph nodes"
        ],
        [
          "KRAS Status",
          "KRAS status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "Tumor Stage",
        "Histologic Grade"
      ],
      "remaining_candidate_features": [
        "performance status (ECOG)",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin level",
        "bilirubin level",
        "creatinine level",
        "presence of synchronous primary colon cancer",
        "history of tumor-related obstructions",
        "history of colonic perforation",
        "history of other malignancies within the past 5 years",
        "history of cardiovascular conditions (e.g., high blood pressure, angina, congestive heart failure, myocardial infarction, heart disease)",
        "history of pulmonary conditions (e.g., pulmonary fibrosis, interstitial pneumonitis)",
        "history of allergic reactions to monoclonal antibody therapy or platinum compounds",
        "presence of human anti-mouse antibodies (HAMA)",
        "HIV status",
        "pregnancy status",
        "history of gastrointestinal bleeding",
        "presence of peripheral sensory or motor neuropathy",
        "history of other concurrent medical conditions",
        "prior chemotherapy or radiotherapy for colon cancer",
        "concurrent use of biologic therapy",
        "chemotherapy",
        "or targeted agents."
      ]
    },
    "processed-gen-response": "Age, sex, race/ethnicity, performance status (ECOG), absolute neutrophil count, platelet count, hemoglobin level, bilirubin level, creatinine level, KRAS status, presence of synchronous primary colon cancer, number of pathologically confirmed positive lymph nodes, history of tumor-related obstructions, history of colonic perforation, history of other malignancies within the past 5 years, history of cardiovascular conditions (e.g., high blood pressure, angina, congestive heart failure, myocardial infarction, heart disease), history of pulmonary conditions (e.g., pulmonary fibrosis, interstitial pneumonitis), history of allergic reactions to monoclonal antibody therapy or platinum compounds, presence of human anti-mouse antibodies (HAMA), HIV status, pregnancy status, history of gastrointestinal bleeding, presence of peripheral sensory or motor neuropathy, history of other concurrent medical conditions, prior chemotherapy or radiotherapy for colon cancer, concurrent use of biologic therapy, chemotherapy, or targeted agents."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Performance Status (ECOG), Absolute Neutrophil Count, Platelet Count, Hemoglobin, Bilirubin, Creatinine, Tumor Stage, Number of Positive Lymph Nodes, KRAS Status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Positive Nodes",
          "Number of Positive Lymph Nodes"
        ],
        [
          "Tumor Stage",
          "Tumor Stage"
        ],
        [
          "KRAS Status",
          "KRAS Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Histologic Grade"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Performance Status (ECOG)",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Hemoglobin",
        "Bilirubin",
        "Creatinine"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Performance Status (ECOG), Absolute Neutrophil Count, Platelet Count, Hemoglobin, Bilirubin, Creatinine, Tumor Stage, Number of Positive Lymph Nodes, KRAS Status"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Performance Status (ECOG), Tumor Stage, Number of Positive Lymph Nodes, Tumor Differentiation, Baseline Carcinoembryonic Antigen (CEA), Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Positive Nodes",
          "Number of Positive Lymph Nodes"
        ],
        [
          "Tumor Stage",
          "Tumor Stage"
        ],
        [
          "KRAS Status",
          "KRAS Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Histologic Grade"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Performance Status (ECOG)",
        "Tumor Differentiation",
        "Baseline Carcinoembryonic Antigen (CEA)",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Performance Status (ECOG), Tumor Stage, Number of Positive Lymph Nodes, Tumor Differentiation, Baseline Carcinoembryonic Antigen (CEA), Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, performance status (ECOG), tumor location, tumor stage, number of positive lymph nodes, presence of tumor adherence to adjacent structures, presence of tumor-related obstructions or colonic perforation, synchronous primary colon cancer, prior surgical procedure, time from surgery to randomization, absolute neutrophil count, platelet count, hemoglobin, bilirubin, creatinine, KRAS status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Positive Nodes",
          "number of positive lymph nodes"
        ],
        [
          "Tumor Stage",
          "tumor stage"
        ],
        [
          "KRAS Status",
          "KRAS status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "Histologic Grade"
      ],
      "remaining_candidate_features": [
        "performance status (ECOG)",
        "tumor location",
        "presence of tumor adherence to adjacent structures",
        "presence of tumor-related obstructions or colonic perforation",
        "synchronous primary colon cancer",
        "prior surgical procedure",
        "time from surgery to randomization",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin",
        "bilirubin",
        "creatinine"
      ]
    },
    "processed-gen-response": "Age, sex, race, performance status (ECOG), tumor location, tumor stage, number of positive lymph nodes, presence of tumor adherence to adjacent structures, presence of tumor-related obstructions or colonic perforation, synchronous primary colon cancer, prior surgical procedure, time from surgery to randomization, absolute neutrophil count, platelet count, hemoglobin, bilirubin, creatinine, KRAS status."
  }
}